On Aug. 27, 2025, a new fun created by Allen’s estate under the late Microsoft co-founder’s instructions, was…
On Aug. 25, 2025, AbbVie and Gilgamesh Pharmaceuticals announced a definitive agreement under which AbbVie will acquire Gilgamesh’s…
On Aug. 18, 2025, Skyhawk Therapeutics announces a strategic research collaboration with Merck KGaA, Darmstadt, Germany. The collaboration…
On Aug. 6, 2025, Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ (dordaviprone)…
On Aug. 1, 2025, Tissium announced it has begun offering surgeons a new solution based on a biopolymer…
On Jul. 31, 2025, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing footprint…
On Jul. 29, 2025, Texas A&M study finds immersive VR nature experiences improve mood and quality of life….
On Jul. 28, 2025, a study published in Nature Neuroscience shows that potential contact with approaching infectious avatars,…
On Jul. 28, 2025, Kaiser Permanente Washington Health Research Institute (KPWHRI) and Kaiser Permanente Center for Health Research…
On Jul. 24, 2025, an analysis of studies incorporating data from almost 30 million people has highlighted the…
On Jul. 23, 2025, research at Tufts and elsewhere has revealed the eight essential nutrients that make up…
On Jul. 18, 2025, The Environmental Protection Agency (EPA) said it is eliminating its research and development arm…
On Jul. 11, 2025, findings from Northwestern University study show the brain protein tied to CTE is not…
On Jul. 9, 2025, Eli Lilly announced that the U.S. Food and Drug Administration (FDA) has approved a…
On Jul. 3, 2025, a study in the journal Science presents compelling new evidence that neurons in the…
On Jun. 30, 2025, a University of Oxford led study reported that a drug used for Parkinson’s disease…
On Jun. 16, 2025, Supernus Pharmaceuticals and Sage Therapeutics announced a definitive agreement for Supernus to acquire Sage…
On Jun. 16, 2025, the Allen Institute announced that for the first time ever, scientists have developed a…
On Jun. 16, 2025, BrainStorm Cell Therapeutics announced new survival data from 10 participants in its Expanded Access…
On Jun. 11, 2025, researchers from the Wellcome Sanger Institute, Centre of Genomic Regulation (CRG) and Institute for…
On Jun. 11, 2025, researchers at the University of California, Davis, announced they have developed an investigational brain-computer…
On Jun. 5, 2025, LinusBio announced ClearStrand-ASD™, a first-of-its-kind diagnostic aid for autism spectrum disorder (ASD). ClearStrand-ASD is…
On May 30, 2025, researchers from Curtin Medical School reported that they have found that men who carry…
On May 27, 2025, a research team from the University of Washington Medical Center and the University of…
On May 22, 2025, an interdisciplinary group of researchers at UW Medicine and the University of Washington announced…
On May 16, 2025, the U.S. Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose…
On May 15, 2025, a University of Colorado–led case report in Emerging Infectious Diseases, describes a 58-year-old woman…
On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…
On May 15, 2025, the Allen Institute announced the launch of CellScapes, a bold new research initiative aimed at…
On May 7, 2025, Howard Hughes Medical Institute Investigator Charles Zuker and members of his Columbia University lab…